An observational study of benzodiazepine prescription during inpatient alcohol detoxification for patients with vs. without chronic pretreatment with high-dosage baclofen

Fundam Clin Pharmacol. 2018 Apr;32(2):200-205. doi: 10.1111/fcp.12339. Epub 2018 Jan 11.

Abstract

High-dose baclofen is prescribed as a maintenance treatment to reduce alcohol use in patients with alcohol use disorder. Nevertheless, some patients still have massive alcohol intakes and require inpatient alcohol withdrawal. To compare the oral dose of benzodiazepine prescribed to manage alcohol withdrawal symptoms in patients with vs. without steady-state pretreatment with high-dose baclofen. Retrospective chart review study. Prescribed benzodiazepine dose expressed in diazepam-equivalent was compared between groups. Thirty-one patients were assessed in the high-dose maintenance baclofen group and compared to 31 matched patients not receiving baclofen. No statistically significant difference was evident between groups regarding levels of benzodiazepines prescribed. The mean diazepam-equivalent dose during the first 7 days was 294 ± 149 mg in the baclofen group vs. 310 ± 133 mg (t-test = 0.440, P = 0.661) in matched controls. Steady-state high-dose baclofen before an inpatient alcohol cessation hospitalization does not lower the needed benzodiazepine dose in the management of alcohol withdrawal symptoms.

Keywords: GABA receptors; alcohol withdrawal; baclofen; benzodiazepine dose; clinical management.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Administration, Oral
  • Adult
  • Alcohol Drinking / adverse effects
  • Alcohol Drinking / physiopathology
  • Alcohol Drinking / prevention & control*
  • Alcohol Drinking / psychology
  • Alcoholism / diagnosis
  • Alcoholism / drug therapy*
  • Alcoholism / physiopathology
  • Alcoholism / psychology
  • Baclofen / administration & dosage*
  • Baclofen / adverse effects
  • Diazepam / administration & dosage*
  • Diazepam / adverse effects
  • Female
  • GABA Modulators / administration & dosage*
  • GABA Modulators / adverse effects
  • GABA-B Receptor Agonists / adverse effects
  • GABA-B Receptor Agonists / therapeutic use*
  • Humans
  • Inpatients*
  • Male
  • Middle Aged
  • Oxazepam / administration & dosage*
  • Oxazepam / adverse effects
  • Retrospective Studies
  • Substance Withdrawal Syndrome / diagnosis
  • Substance Withdrawal Syndrome / drug therapy*
  • Substance Withdrawal Syndrome / physiopathology
  • Substance Withdrawal Syndrome / psychology
  • Time Factors
  • Treatment Outcome

Substances

  • GABA Modulators
  • GABA-B Receptor Agonists
  • Oxazepam
  • Baclofen
  • Diazepam